Bleeding diathesis is a common complication of acute promyelocyctic le
ukaemia (APL). Multiple haemostatic defects are found in most patients
with APL, which often worsen following cytoreductive chemotherapy. Be
sides thrombocytopenia, most patients develop disseminated intravascul
ar coagulation, systemic fibrinolysis or both. A major aim in treating
haemostatic defects of APL is to prevent death or disability from ble
eding until chemotherapy clears the malignant promyelocytes from the b
lood and bone marrow. The therapeutic options are discussed in this re
view and practical guidelines for treatment are outlined.